Updates

Scapa

June 2018

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Scapa had a positive year end update with health care revenues growing 3.8%, including second half sales growth of 6.8% despite currency headwinds. Margins are expected to be above 15% reflecting investment in integrating two technology transfers.The industrial division has further delivered on its asset optimisation strategy with the Asian restructuring helping drive up margins. Healthy cash flow ensured net debt was just £3.8m after spending nearly £21m on acquisitions.Earlier Scapa announced another acquisition of BioMed for an initial US$13m, with another US$13m conditional on future performance. BioMed, based in Dallas, Texas, is a leading manufacturer of gels, creams, lotions, liquids and powders in the woun ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Future - Digital publishing business eyes further acquisitions

Polypipe

Scapa - Revised bid at 215p voted through (May 2021)

Scapa - Receives bid approach (March 2021)

Scapa - Third beat since August for industrial and medical tapes manufacturer (January 2021)

Scapa (December 2020)

Scapa - Revenues ahead of plan (October 2020)

Scapa (September 2020)

Scapa (July 2020)

Scapa (January 2020)

Scapa (February 2019)

Scapa - Another acquisition (November 2018)

Scapa - Another broker upgrade (August 2018)

Scapa - Numis has three year target price of £8 (February 2018)

Scapa (December 2017)

Scapa (October 2017)

Scapa - Industrial tapes and healthcare group planning acquisition push (August 2017)

Scapa - Gain to date: 493% (June 2017)

Scapa - Gain to date: 380% (February 2017)

Scapa - Shares register new high of 304p (December 2016)

Scapa - Shares briefly hit high of 295p (August 2016)

Scapa - Shares hit new high of 252p (June 2016)

Scapa - Healthcare enjoys 20% profit growth (January 2016)

Scapa - Another upgrade sends shares over Â£2 (July 2015)

Scapa - Shares soar to over 170p (June 2015)

Scapa - Acquires First Water (April 2015)

Scapa - Industrial and medical tapes business forecast to grow eps 46% by 2017 (January 2015)

Scapa - N+1 Singer upgrades forecasts (July 2014)

Scapa - Healthcare side growing rapidly (February 2014)

Scapa - Medical tapes grew profits 53% (July 2013)

Scapa - New 5.1p eps forecast for 2014 (July 2012)

Scapa - Self-help measures drive another upgrade to forecasts (May 2012)

Scapa - Industrial tape firm expanding into higher margin medical markets (March 2012)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X